L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway.
about
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepOxidative Stress and Liver Cancer: Etiology and Therapeutic TargetsUrinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver diseaseEvaluation of the effects of L-carnitine on medaka (Oryzias latipes) fatty liver.Administration of Non-Absorbable Antibiotics to Pregnant Mice to Perturb the Maternal Gut Microbiota Is Associated with Alterations in Offspring Behavior.Systemic regulation of L-carnitine in nutritional metabolism in zebrafish, Danio rerio.Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?Anti-adipogenic and antiviral effects of l-carnitine on hepatitis C virus infection.Oxidative stress balance is dysregulated and represents an additional target for treating cholangiocarcinoma.Serum level of taurine would be associated with the amelioration of minimal hepatic encephalopathy in cirrhotic patients.Oxidative stress controlling agents are effective for small intestinal injuries induced by non-steroidal anti-inflammatory drugs.Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.Mitochondrial network responses in oxidative physiology and disease.Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors.Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats.Evaluating effects of L-carnitine on human bone-marrow-derived mesenchymal stem cells.L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis
P2860
Q26771518-108045FE-763A-4AD9-9565-D1F0087DD6CDQ28071678-AE5F02F1-9055-4CEF-A2E6-8B9051904974Q33599564-48E1EFA5-93BF-414F-97BF-0BCD920730BAQ33766037-8218E5AD-DD02-447D-A47E-467EA9B47099Q35899043-F33ABF51-99E6-4FEC-BA01-DB8522108579Q37593270-3B820D39-DCE5-49C5-9492-DEC810792382Q38466831-FC82A6B9-016D-4F13-9330-B05D8D6C9A7EQ40528820-356E56A2-BBA8-4570-BEC1-FEC5F532DE2EQ40737823-619E102B-CC37-411E-B232-B2352546F5C4Q41082489-EE81AD52-F29F-4C1B-908A-5805B59518B4Q46557368-6361FA75-6898-4682-9302-759D845C16DFQ47111743-F5F880FC-71D2-4B6D-88E4-40DB6E5B2DE0Q47661870-AD6B7E8C-C0D0-4701-831E-E43BBE5F50D6Q50077361-01534B11-8D4A-47EB-A123-D56E6287229DQ51277571-A8D1E67C-080C-4543-AFA7-8660AF515761Q52907071-FAEE0448-6BC0-4B01-9F7B-CACC13477FECQ58799829-8CDBF67D-C368-49C6-A1DB-84320CFF5CC1
P2860
L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
L-carnitine prevents progressi ...... tion of mitochondrial pathway.
@ast
L-carnitine prevents progressi ...... tion of mitochondrial pathway.
@en
type
label
L-carnitine prevents progressi ...... tion of mitochondrial pathway.
@ast
L-carnitine prevents progressi ...... tion of mitochondrial pathway.
@en
prefLabel
L-carnitine prevents progressi ...... tion of mitochondrial pathway.
@ast
L-carnitine prevents progressi ...... tion of mitochondrial pathway.
@en
P2093
P2860
P1433
P1476
L-carnitine prevents progressi ...... tion of mitochondrial pathway.
@en
P2093
Akinobu Takaki
Fusao Ikeda
Hidenori Shiraha
Hiroshi Matsushita
Hiroyuki Seki
Hisashi Ishikawa
Kazuhide Yamamoto
Kazuhiro Nouso
Kazuko Koike
Ryuichiro Tsuzaki
P2860
P304
P356
10.1371/JOURNAL.PONE.0100627
P407
P577
2014-07-01T00:00:00Z